Sunanda A. Ranadive

<i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent

Raj N. Misra, Hai‐Yun Xiao, Kyoung S. Kim et al. · Journal of Medicinal Chemistry · 2004 · 251 citations · Full text

Chemoprevention Strategy, Immunology, Pharmacotherapy +19

Discovery of 4-Benzoyl-1-[(4-methoxy-1<i>H</i>- pyrrolo[2,3-<i>b</i>]pyridin-3-yl)oxoacetyl]-2- (<i>R</i>)-methylpiperazine (BMS-378806):  A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions

Tao Wang, Zhongxing Zhang, Owen B. Wallace et al. · Journal of Medicinal Chemistry · 2003 · 205 citations

Cd4-gp120 Interactions, Pharmaceutical Science, Immunology +17

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

Abu T.M. Serajuddin, Sunanda A. Ranadive, Eileen M. Mahoney · Journal of Pharmaceutical Sciences · 1991 · 201 citations

Molecular Pharmacology, Medicinal Chemistry, Reductase Inhibitors Pravastatin +10

Selection of solid dosage form composition through drug–excipient compatibility testing

Abu T.M. Serajuddin, Ajit B. Thakur, Rabin N. Ghoshal et al. · Journal of Pharmaceutical Sciences · 1999 · 200 citations

Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors

Sunanda A. Ranadive, Andrew Chen, Abu T.M. Serajuddin · Pharmaceutical Research · 1992 · 118 citations